The model was adjusted for age, sex, body mass index, hypertension, dyslipidemia, diabetes mellitus, prior MI, prior PCI, prior CABG, mean stent diameter, β-blockers, oral hypoglycemic agents, insulin, baseline LDL-C, baseline TC, baseline HDL-C, and baseline HbA1c for the baseline TyG index and additional adjusted for baseline TG, baseline FPG and the baseline TyG index for the mean TyG index and TyG index variability. This evidence concerns the gene INS and Hypertension.